# A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

> clinical trial · VERIFIED · 2026-08-18

Status: RECRUITING · Sponsor: Biogen · Condition: Muscular Atrophy, Spinal

- Company: Biogen
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07221669

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.